New Blood Test Added to Colorectal Cancer Screening Guidelines for El Paso Residents

The American Cancer Society has updated its colorectal cancer screening guidelines to include blood tests for adults aged 45 and older at average risk who have not undergone traditional screening methods. The newly recommended Shield test, approved by the FDA in 2024, aims to increase screening rates among those hesitant to undergo colonoscopies or stool tests. While blood tests are not the primary choice due to lower sensitivity in detecting precancerous conditions, they provide an alternative for individuals who decline other options. Early detection through screening is crucial, as it significantly improves survival rates, with over 90% of patients surviving at least five years if diagnosed early. Residents are encouraged to discuss their screening options with healthcare providers.

Key Details: • Adults aged 45 and older at average risk should consider new blood tests. • The Shield test is the first FDA-approved blood test for colorectal cancer screening. • Screening can dramatically improve survival rates if cancer is detected early. • Individuals with a family history of colorectal cancer should consult their doctor for personalized recommendations.